CASI Pharmaceuticals
CASI
#10579
Rank
NZ$7.3 M
Marketcap
NZ$0.36
Share price
0.00%
Change (1 day)
-89.14%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): NZ-$4.65

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$4.75. In 2024 the company made an earnings per share (EPS) of NZ-$4.39 a decrease over its 2023 EPS that were of NZ-$3.46.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$4.656.06%
2024NZ-$4.3926.73%
2023NZ-$3.46-32.89%
2022NZ-$5.1611.9%
2021NZ-$4.61-38.44%
2020NZ-$7.49-8.96%
2019NZ-$8.2250%
2018NZ-$5.4877.78%
2017NZ-$3.085.88%
2016NZ-$2.91-22.73%
2015NZ-$3.77-76.09%
2014NZ-$15.76318.18%
2013NZ-$3.77-71.79%
2012NZ-$13.3665.96%
2011NZ-$8.05-50%
2010NZ-$16.10-18.97%
2009NZ-$19.87-63.64%
2008NZ-$54.643.57%
2007NZ-$52.76-60.56%
2006NZ-$133.7997.22%
2005NZ-$67.83-2.7%
2004NZ-$69.72-45.59%
2003NZ-$128.13-61.8%
2002NZ-$335.41-25.52%
2001NZ-$450.35-21.38%
2000NZ-$572.8313.86%
1999NZ-$503.11149.53%
1998NZ-$201.6298.15%
1997NZ-$101.7510.2%
1996NZ-$92.33